115 related articles for article (PubMed ID: 15084702)
41. Harmful potential of viral vectors fuels doubts over gene therapy.
Check E
Nature; 2003 Jun; 423(6940):573-4. PubMed ID: 12789298
[No Abstract] [Full Text] [Related]
42. Success for gene therapy: render unto Caesar that which is Caesar's.
Qiao J; Diaz RM; Vile RG
Genome Biol; 2004; 5(8):237. PubMed ID: 15287968
[TBL] [Abstract][Full Text] [Related]
43. The trials of gene therapy.
Nature; 2002 Nov; 420(6912):107. PubMed ID: 12432344
[No Abstract] [Full Text] [Related]
44. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
45. Bubble babies and bathwater.
Nat Biotechnol; 2002 Nov; 20(11):1063. PubMed ID: 12410236
[No Abstract] [Full Text] [Related]
46. Chance or necessity? Insertional mutagenesis in gene therapy and its consequences.
Baum C; von Kalle C; Staal FJ; Li Z; Fehse B; Schmidt M; Weerkamp F; Karlsson S; Wagemaker G; Williams DA
Mol Ther; 2004 Jan; 9(1):5-13. PubMed ID: 14741772
[TBL] [Abstract][Full Text] [Related]
47. Occurrence of leukaemia following gene therapy of X-linked SCID.
Kohn DB; Sadelain M; Glorioso JC
Nat Rev Cancer; 2003 Jul; 3(7):477-88. PubMed ID: 12835668
[TBL] [Abstract][Full Text] [Related]
48. Gene therapy for immune disorders: good news tempered by bad news.
Puck JM; Malech HL
J Allergy Clin Immunol; 2006 Apr; 117(4):865-9. PubMed ID: 16630946
[TBL] [Abstract][Full Text] [Related]
49. Clinical gene-marking of mesenchymal cells.
Horwitz EM; Kasow KA; Hofmann TJ
Cytotherapy; 2003; 5(3):194-6. PubMed ID: 12850786
[No Abstract] [Full Text] [Related]
50. Gene therapy for SCID--a complication after remarkable progress.
Buckley RH
Lancet; 2002 Oct; 360(9341):1185-6. PubMed ID: 12401240
[No Abstract] [Full Text] [Related]
51. Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients.
Romano G; Marino IR; Pentimalli F; Adamo V; Giordano A
Drug News Perspect; 2009 May; 22(4):185-96. PubMed ID: 19536363
[TBL] [Abstract][Full Text] [Related]
52. [Development and application of gene therapy technologies].
Ozawa K
Uirusu; 2004 Jun; 54(1):49-57. PubMed ID: 15449904
[TBL] [Abstract][Full Text] [Related]
53. The gene genie?
Harris F; Chatfield L; Phoenix DA
Biologist (London); 2002 Feb; 49(1):25-8. PubMed ID: 11852282
[TBL] [Abstract][Full Text] [Related]
54. Gene therapy fulfilling its promise.
Kohn DB; Candotti F
N Engl J Med; 2009 Jan; 360(5):518-21. PubMed ID: 19179320
[No Abstract] [Full Text] [Related]
55. Gene therapy: is IL2RG oncogenic in T-cell development?
Pike-Overzet K; de Ridder D; Weerkamp F; Baert MR; Verstegen MM; Brugman MH; Howe SJ; Reinders MJ; Thrasher AJ; Wagemaker G; van Dongen JJ; Staal FJ
Nature; 2006 Sep; 443(7109):E5; discussion E6-7. PubMed ID: 16988660
[TBL] [Abstract][Full Text] [Related]
56. A review of gene therapy for haematological disorders.
Nathwani AC; Davidoff AM; Linch DC
Br J Haematol; 2005 Jan; 128(1):3-17. PubMed ID: 15606545
[TBL] [Abstract][Full Text] [Related]
57. For gene therapy, now-quantified risks are deemed troubling.
Twombly R
J Natl Cancer Inst; 2003 Jul; 95(14):1032-3. PubMed ID: 12865444
[No Abstract] [Full Text] [Related]
58. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.
Hacein-Bey-Abina S; Garrigue A; Wang GP; Soulier J; Lim A; Morillon E; Clappier E; Caccavelli L; Delabesse E; Beldjord K; Asnafi V; MacIntyre E; Dal Cortivo L; Radford I; Brousse N; Sigaux F; Moshous D; Hauer J; Borkhardt A; Belohradsky BH; Wintergerst U; Velez MC; Leiva L; Sorensen R; Wulffraat N; Blanche S; Bushman FD; Fischer A; Cavazzana-Calvo M
J Clin Invest; 2008 Sep; 118(9):3132-42. PubMed ID: 18688285
[TBL] [Abstract][Full Text] [Related]
59. Severe immunodeficiencies: bone marrow transplantation or gene therapy?
Mariani SM
MedGenMed; 2003 Jun; 5(2):19. PubMed ID: 14603118
[No Abstract] [Full Text] [Related]
60. [Current status and future prospective of gene therapy].
Kaneda Y
Nihon Rinsho; 2005 Dec; 63 Suppl 12():469-74. PubMed ID: 16416836
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
